SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTIVITY OF NIFUROXAZIDE AND ASCORBIC ACID EUTECTIC MIXTURE

المؤلفون

  • Bouchra Chaib usthb
  • Fayrouz Djellouli Laboratory of thermodynamics and molecular modelling, faculty of chemistry, BP32, El-Alia, Bab-Ezzouar 16111, USTHB, Algiers, Algeria
  • Abdallah Dahmani Laboratory of thermodynamics and molecular modelling, faculty of chemistry, BP32, El-Alia, Bab-Ezzouar 16111, USTHB, Algiers, Algeria

الكلمات المفتاحية:

Nifuroxazide، Ascorbic acid، eutectic mixture، DSC

الملخص

This study investigated the formation of a eutectic mixture comprising an active pharmaceutical ingredient (API), an oral antibiotic, and ascorbic acid as a coformer. The aim was to evaluate the nature of the resulting mixture and to explore strategies for enhancing its dissolution rate, ultimately improving bioavailability. The eutectic mixture was synthesized using the neat grinding method in an agate mortar, chosen for its ability to facilitate molecular interactions without the need for solvents. Characterization of the mixture was performed using powder X-ray diffraction (PXRD) to analyze crystallographic changes, infrared spectroscopy (IR) to detect functional group interactions, and nuclear magnetic resonance (NMR) to assess molecular-level interactions. Additionally, differential scanning calorimetry (DSC) was employed for thermal analysis to confirm the thermal behavior and stability of the mixture. To study its biological activity a test was made against Escherichia Coli, Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans.

التنزيلات

بيانات التنزيل غير متوفرة بعد.

المراجع

Covaci, O. I. et al. Bringing new life into old drugs: A case study on nifuroxazide polymorphism. CrystEngComm, (2017), 19, 3584–3591.

Bailly, C. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment. Drug Discovery Today vol. (2019), 24 1930–1936.

Masunari, A. & Tavares, L. C. A new class of nifuroxazide analogues: Synthesis of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus. Bioorg Med Chem, (2007), 15, 4229–4236.

Nicolov, M. et al. Cocrystal formation of betulinic acid and ascorbic acid: Synthesis, physico-chemical assessment, antioxidant, and antiproliferative activity. Front Chem, (2019) 7.

Sathisaran, I. & Dalvi, S. V. Cocrystallization of carbamazepine with amides: Cocrystal and eutectic phases with improved dissolution. J Mol Struct (2019), 1193, 398–415.

Pantwalawalkar, J., More, H., Bhange, D., Patil, U. & Jadhav, N. Novel curcumin ascorbic acid cocrystal for improved solubility. J Drug Deliv Sci Technol (2021), 61.

Zhang, H. et al. Novel Ascorbic Acid Co-Crystal Formulations for Improved Stability. Molecules, (2022) 27.

Nangia, A. K. & Desiraju, G. R. Crystal Engineering: An Outlook for the Future. Angewandte Chemie, (2019),131, 4142–4150.

Cherukuvada, S. On the issues of resolving a low melting combination as a definite eutectic or an elusive cocrystal: A critical evaluation. Journal of Chemical Sciences, (2016), 128, 487–499.

Bazzo, G. C., Pezzini, B. R. & Stulzer, H. K. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs. International Journal of Pharmaceutics vol, (2020), 588.

Coyote-Dotor, G. et al. Synthesis, characterization, and intrinsic dissolution studies of drug–drug eutectic solid forms of metformin hydrochloride and thiazide diuretics. Pharmaceutics, (2021), 13.

Cherukuvada, S. & Nangia, A. Fast dissolving eutectic compositions of two anti-tubercular drugs. CrystEngComm, (2012) 14, 2579–2588.

Bazzo, G. C., Mostafa, D., França, M. T., Pezzini, B. R. & Stulzer, H. K. How tenofovir disoproxil fumarate can impact on solubility and dissolution rate of efavirenz? Int J Pharm 570, (2019).

Araya-Sibaja, A. M., Vega-Baudrit, J. R., Guillén-Girón, T., Navarro-Hoyos, M. & Cuffini, S. L. Drug solubility enhancement through the preparation of multicomponent organic materials: Eutectics of lovastatin with carboxylic acids. Pharmaceutics, (2019), 11.

Sarraguça, M. C., Ribeiro, P. R. S., Nunes, C. & Seabra, C. L. Solids Turn into Liquids—Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility. Pharmaceuticals, (2022), 15.

Kissi, E. O., Khorami, K. & Rades, T. Determination of stable co-amorphous drug–drug ratios from the eutectic behavior of crystalline physical mixtures. Pharmaceutics, (2019), 11.

Palanisamy, V., Sanphui, P., Palanisamy, K., Prakash, M. & Bansal, A. K. Design of Ascorbic Acid Eutectic Mixtures with Sugars to Inhibit Oxidative Degradation. Front Chem, (2022) 10.

Toral, M. I., Paine, M., Leyton, P. & Richter, P. Determination of attapulgite and nifuroxazide in pharmaceutical formulations by sequential digital derivative spectrophotometry. J AOAC Int 87, (2004), 1323–1328.

Umer, A., Naveed, S., Ramzan, N., Rafique, M. S. & Imran, M. A green method for the synthesis of copper nanoparticles using l-ascorbic acid. Revista Materia, (2014), 19, 197–203.

Fandaruff, C. et al. Saquinavir-Piperine Eutectic Mixture: Preparation, Characterization, and Dissolution Profile. Pharmaceutics, (2023), 15.

Alkhawaja, B. et al. Structural insights into novel therapeutic deep eutectic systems with capric acid using 1D, 2D NMR and DSC techniques with superior gut permeability. RSC Adv, (2024) 14, 14793–14806.

التنزيلات

منشور

2024-12-30

كيفية الاقتباس

Chaib, B., Djellouli, . F., & Dahmani , A. (2024). SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTIVITY OF NIFUROXAZIDE AND ASCORBIC ACID EUTECTIC MIXTURE. Journal of the Algerian Chemical Society, 1(1), 44–53. استرجع في من https://www.jacs-dz.org/index.php/jacs/article/view/340

إصدار

القسم

المقالات